Concert Nabs $200M Deal From Avanir to Make Psych Drugs
Xconomy
Lexington, MA-based Concert Pharmaceuticals has found a second partner looking to take advantage of its technology for making deuterium-modified drugs. Concert is announcing today that Aliso Viejo, CA-based Avanir Pharmaceuticals (NASDAQ: AVNR) has …
Concert Pharma snags $200M licensing pact with Avanir
Avanir Pharmaceuticals and Concert Pharmaceuticals Announce License Agreement …
Avanir Pharmaceuticals and Concert Pharmaceuticals Announce License Agreement